Latest filing published 27 Dec 2022 for ABIOMED INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Todd A. Trapp in Abiomed Inc, where the filings describe the role as finance chief. Over a trading history stretching from 16 May 2021 to 22 December 2022, the count stands at 12 filings.
The open-market record consists of 4 sales worth €1.0M, with no purchase. Besides market trades, the filings include 7 share grants. 2022 to date brings no purchases and 4 sales.
The latest filing, published on 27 December 2022, reports a transaction in Abiomed Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations